D

Dynex Technologies

Automates ELISA and chemiluminescence microplates

Overview

Dynex Technologies develops and manufactures fully automated ELISA and chemiluminescence microplate instruments and related accessories. These systems automate the processing of diagnostic tests in laboratories by handling continuous sample loading, performing automated results calculations, and offering an intuitive graphical user interface to minimize training and hands-on time. The products are designed for high-throughput operations and regulatory compliance, supported by software that streamlines workflows and quality controls. Dynex serves a global market with direct sales in the United States and distributor partnerships in over 120 countries, and has installed more than 8,500 instruments worldwide. The company aims to boost laboratory productivity, accuracy, and compliance in the diagnostics field through reliable automation and strong customer service.

Work here?Claim your company

About Dynex Technologies

Simplify's Rating
Why Dynex Technologies is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

HardwareIndustrial & ManufacturingEnterprise SoftwareHealthcare

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Chantilly, VA

Founded

1952

Get referred to Dynex Technologies

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • ALPCO partnership now offers automated multiplex GI biomarker testing, expanding assay menu depth.
  • Dynex service plans on November 9, 2026 still sell installation, training, and premium agreements.
  • Monterey’s operational discipline can improve manufacturing, refurbishment, and customer support margins by 2027.

What critics are saying

  • Roche launched an automated ELISA analyzer in May 2026, intensifying premium workflow competition.
  • Dynex depends on aging platform families; replacement cycles can freeze if customers standardize elsewhere.
  • If Monterey integration stumbles, service quality slips and erodes trust across warranties, consumables, and renewals.

What makes Dynex Technologies unique

  • November 6, 2026 Monterey Automation acquisition preserves DS2, DSX, and Agility continuity.
  • Dynex’s installed base spans 8,500 systems worldwide, anchoring consumables and service revenue.
  • 21 CFR Part 11 software and continuous sample loading fit regulated clinical labs.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

6 month growth

0%

1 year growth

3%

2 year growth

3%
Dynex Technologies
Nov 6th, 2026
Monterey Automation acquires DYNEX Technologies; Adam Webster to lead both firms

Monterey Automation has acquired DYNEX Technologies, a provider of laboratory automation solutions. The companies announced the deal from Reno, Nevada, and Chantilly, Virginia. No financial terms were disclosed. Adam Webster, chief executive officer of Monterey, will also lead DYNEX as president and chief executive officer. Monterey has worked with DYNEX instruments and customers for more than a decade. The deal pairs DYNEX's product development and manufacturing with Monterey's operations, quality management, and instrument lifecycle experience. The aim is to improve product quality, operational performance, and customer support. DYNEX's DS2, DSX, and Agility platforms remain central to the business. Customer contacts, service agreements, warranties, and pricing stay in place. "My leadership is only as strong as my team," Webster said.

GlobeNewswire
Nov 12th, 2024
Elisa Analyzers Market Size Forecast To Hit Usd 960.7 Million By 2031, Growing At A Cagr Of 5.9%| Says Transparency Market Research, Inc.

Wilmington, Delaware, United States, Transparency Market Research, Inc. , Nov. 12, 2024 (GLOBE NEWSWIRE) -- The ELISA analyzers market was valued at US$ 574.7 million in 2022. Between 2023 and 2031, it is expected to expand at a CAGR of 5.9% and surpass US$ 960.7 million during the forecast period. The development of technology could lead to ELISA analyzers that are more sophisticated and efficient. Faster analysis times, improved automation, and enhanced sensitivity could increase adoption.ELISA (Enzyme-Linked Immunosorbent Assay) is widely used in the medical field and in pharmaceutical research, among other fields

ALPCO
Dec 15th, 2022
5 Reasons to Add GI Biomarker Testing to Your Lab’s Menu

ALPCO has partnered with Dynex Technologies to offer the first automated multiplex GI protein biomarker test.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Dynex Technologies right now.

Find jobs on Simplify and start your career today

We update Dynex Technologies's jobs every few hours, so check again soon!Browse all jobs